As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
News-Medical.Net on MSN13d
Natural compounds identified as potential inhibitors of SARS-CoV-2 spike proteinSmall-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...
The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...
AZoLifeSciences on MSN6d
New AI Model Helps Predict Future Mutations in SARS-CoV-2 Spike ProteinIt's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...
A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants ... This area, within the Spike N-terminal domain, or NTD, had been overlooked because ...
Shaibani, A. , Maallah, M. and Maallah, A. (2025) Antiviral Activity of Natural Compounds Immuno Formula Shiban2/5 against ...
MARCHF7 or UBR5 was knocked down by siRNA in Caco2 cells with stable expression of SARS-CoV-2 N protein. Twenty-four hours later, cells were infected with SARS-CoV-2 virus-like-particles (MOI:0.1), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback